All In Biotech

Drug Trial Radar · NCT02390947

Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma(FACT)

A Multicenter,Randomized, Double-blind, Placebo-controlled Trial of Famitinib in Patients With Advanced Colorectal Adenocarcinoma

Last checked: Nov 20, 2026Latest source record: Dec 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 543 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

543

Actual

Start

Jan 2015

Primary completion

Feb 2019

Study completion Jul 2019

Sponsor

Sponsor type
Industry
First posted
Mar 18, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Famitinib is a tyrosin-inhibitor agent targeting at c-Kit, VEGFR2, PDGFR, VEGFR3, Flt1 and Flt3, whose anti-tumor and anti-angiogenesis effects have been validated in preclinical tests. In PhaseⅡb study, a significantly improved Progression Free Survival (PFS) was found in patients with advanced colorectal cancer treated with Famitinib compared to placebo. On the other hand, the toxicity of Famitinib was manageable in both PhaseⅠand Ⅱb studies. The purpose of this study is to determine whether Famitinib can improve Overall Survival (OS) compared with placebo in total 540 patients with advanced colorectal cancer who have failed in previously received at least two lines of standard chemotherapy.

Conditions

  • Colorectal Cancer Metastatic
  • Colorectal Cancer Recurrent

Interventions

  • FamitinibDrug

    25 mg p.o. qd

  • PlaceboDrug

    25 mg p.o. qd

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival(OS)Time frame: 3 years

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • Beijing Cancer Hospital, Peking University

    Beijing, Beijing Municipality, China

  • Beijing Chao-yang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Chinese Academy of Medical Sciences Cancer Hospital

    Beijing, Beijing Municipality, China

  • PLA Hospital 301

    Beijing, Beijing Municipality, China

  • The Third Affiliated Hospital of The Third Military Medical University

    Chongqing, Chongqing Municipality, China

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China

  • Cancer center, Sun Yet-sen University

    Guangzhou, Guangdong, China

  • The First Affiliated Hospital of Guangzhou Medical University of Chinese Medicine

    Guangzhou, Guangdong, China

  • Cancer Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China

  • Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China

  • Hainan General Hospital

    Hainan, Hainan, China

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, China

  • The first affiliated hospital of Xinxiang medical university

    Xinxiang, Henan, China

  • Cancer Hospital of Henan Province

    Zhengzhou, Henan, China

  • The First affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Union Hospital of Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Wuhan General Hospital of Guangzhou Military

    Wuhan, Hubei, China

  • Cancer Hospital of Hunan Province

    Changsha, Hunan, China

  • The Third Xiangya Hospital of Cental South University

    Changsha, Hunan, China

  • The First People's Hospital of Changzhou

    Changzhou, Jiangsu, China

  • Cancer Hospital of Jiangsu Province

    Nanjing, Jiangsu, China

  • The Second Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, China

  • The Affiliated Hospital of Xuzhou Medical Collage

    Xuzhou, Jiangsu, China

  • Cancer Hospital of Jiangxi Province

    Nanchang, Jiangxi, China

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Cancer Hospital of Jilin province

    Changchun, Jilin, China

  • The First Affiliated Hospital of Jilin University

    Changchun, Jilin, China

  • Cancer Hospital of Liaoning Province

    Shenyang, Liaoning, China

  • Chinese Medical University First Hospital

    Shenyang, Liaoning, China

  • Fudan University Cancer Hospital

    Shanghai, Shanghai Municipality, China

  • Ruijin Hospital, Shanghai jiaotong University, School of Medicine

    Shanghai, Shanghai Municipality, China

  • Shanghai General Hospital

    Shanghai, Shanghai Municipality, China

  • Zhongshan Hospital of Fudan University

    Shanghai, Shanghai Municipality, China

  • Cancer Hospital of Shanxi Province

    Xian, Shanxi, China

  • Tangdu Hospital of The Fouth Military Medical University

    Xian, Shanxi, China

  • Cancer Hospital of Tianjin City

    Tianjin, Tianjin Municipality, China

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.